Management of anemia in chronic kidney disease

Authors

DOI:

https://doi.org/10.22141/2307-1257.10.2.2021.234324

Keywords:

chronic kidney disease, anemia, erythropoiesis-sti­mulating agents, epobiocrinum

Abstract

Anemia is the most common complication of chronic kidney disease (CKD) associated with reduced quality of life and increased morbidity and mortality. The purpose of this review was to discuss the management of anemia in CKD. The following topics are considered: prevalence of anemia, symptoms, and impact of anemia in CKD, diagnosis, iron replacement therapy, and erythropoiesis-stimulating agents.

Downloads

Download data is not yet available.

References

Evans M, Bower H, Cockburn E, Jacobson SH, Barany P, Carrero JJ. Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis. Clin Kidney J. 2020 May 1;13(5):821-827. doi: 10.1093/ckj/sfaa054.

Stack AG, Alghali A, Li X, Ferguson JP, Casserly LF, Cronin CJ, Reddan DN, Hussein W, Elsayed ME. Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study. Clin Kidney J. 2018 Feb;11(1):99-107. doi: 10.1093/ckj/sfx060.

KDIGO Anemia Working Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl (2011). 2012 Aug;2(4):280. doi: 10.1038/kisup.2012.38.

Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 Jan 1;36(1):129-136. doi: 10.1093/ndt/gfz192.

Lopes MB, Tu C, Zee J, Guedes M, et al. A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps. Sci Rep. 2021 Jan 19;11(1):1784. doi: 10.1038/s41598-020-79254-6.

NICE. NICE guideline: Chronic Kidney Disease: Managing Anaemia. Available at: https://www.nice.org.uk/guidance/ng8. Accessed: 03 June 2015.

Sakaguchi Y, Hamano T, Wada A, Masakane I. Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis. J Am Soc Nephrol. 2019 Jun;30(6):1037-1048. doi: 10.1681/ASN.2018101007.

Minutolo R, Garofalo C, Chiodini P, et al. Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease. Nephrol Dial Transplant. 2021 Jan 25;36(2):267-274. doi: 10.1093/ndt/gfaa088.

Cases A, Puchades MJ, de Sequera P, et al. Iron replacement therapy in the management of anaemia in non-dialysis chronic renal failure patients: Perspective of the Spanish Nephrology Society Anaemia Group. Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):123-136. doi: 10.1016/j.nefro.2020.11.003.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.

Fishbane S, Hirsch JS. Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19. Am J Kidney Dis. 2020 Sep;76(3):303-305. doi: 10.1053/j.ajkd.2020.05.002.

Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020 Dec;41(12):1539-1546. doi: 10.1038/s41401-020-00554-8.

Khodour Y, Kaguni LS, Stiban J. Iron-sulfur clusters in nucleic acid metabolism: Varying roles of ancient cofactors. Enzymes. 2019;45:225-256. doi: 10.1016/bs.enz.2019.08.003.

Liu W, Zhang S, Nekhai S, Liu S. Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival. Curr Clin Microbiol Rep. 2020 Apr 20:1-7. doi: 10.1007/s40588-020-00140-w.

Wong MMY, Tu C, Li Y, et al; CKDopps Investigators. Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clin Kidney J. 2019 Aug 3;13(4):613-624. doi: 10.1093/ckj/sfz091.

Levin A. Therapy for Anemia in Chronic Kidney Disease - New Interventions and New Questions. N Engl J Med. 2021 Apr 29;384(17):1657-1658. doi: 10.1056/NEJMe2103937.

Mathias SD, Blum SI, Sikirica V, Johansen KL, Colwell HH, Okoro T. Symptoms and impacts in anemia of chronic kidney disease. J Patient Rep Outcomes. 2020 Jul 29;4(1):64. doi: 10.1186/s41687-020-00215-8.

Cases-Amenós A, Martínez-Castelao A, Fort-Ros J, et al; Investigadores del Estudio Micenas I. Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in Catalonia: MICENAS I study. Nefrologia. 2014;34(2):189-98. English, Spanish. doi: 10.3265/Nefrologia.pre2013.Dec.12261.

Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, Sung S. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci. 2017 Feb;32(2):249-256. doi: 10.3346/jkms.2017.32.2.249.

Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943.

Kidney Disease: Improving Global Outcomes (KDIGO) СKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter Suppl. 2013;3:1-150.

Ministry of Health of Ukraine. Order dated February 11, 2016 No 89: Unified clinical protocol for secondary (specialized) and tertiary (highly specialized) medical care "Treatment of patients with stage V chronic kidney disease with anemia. Available from: http://inephrology.kiev.ua/?page_id=1236.

Ministry of Health of Ukraine. Order dated July 20, 2005 No 365: On the approval of the protocols for the provision of medical care to children in the specialty Pediatric Nephrology: the protocol for the treatment of children with pyelonephritis; protocol for the treatment of children with chronic renal failure. Available from: https://zakon.rada.gov.ua/rada/show/v0365282-05#Text

Downloads

Published

2021-09-10

How to Cite

Kushnirenko, S. (2021). Management of anemia in chronic kidney disease. KIDNEYS, 10(2), 88–92. https://doi.org/10.22141/2307-1257.10.2.2021.234324

Issue

Vol. 10 No. 2 (2021)

Section

Looking at the problem

License

Copyright (c) 2021 S.V. Kushnirenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.